The FDA Sends Amarin A Letter In Their First Amendment Court Battle [Drug and Device Law]

John Sullivan, a member of Cozen O’Connor’s Commercial Litigation Department, discusses the ongoing First Amendment case between Amarin Pharma, Inc. and the FDA, originally discussed here. Since then, Amarin has moved for a preliminary injunction, which is both unsurprising and convincing, and lays out the truthful, non-misleading statements that it wanted to provide to health care providers.

To read the article, click here.

Share Page On LinkedIn

Related Attorneys

John J. Sullivan


(212) 453-3729

Related Practices